To investigate the metabolic vulnerability of cancer cells regulated by CD151, we conducted an untargeted metabolomic analysis in osteosarcoma cells using liquid chromatography coupled with mass spectrometry (LC/MS) analysis. Here, CD151 is linked to cancer.